Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lengyel

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Transplantation Proceedings|December 10, 2013
Successful treatment of renal failure caused by multiple myeloma with HLA-identical living kidney and bone marrow transplantation: a case reportL Wagner, L Lengyel, G Mikala, et al.
Leukemia|October 1, 1994
Molecular background of a new case of chronic myelogenous leukemia with bcr-abl chimera mRNA lacking the A2 exonP Páldi-Haris, A Barta, L Lengyel, et al.
Breast (Edinburgh, Scotland)|September 30, 2004
Secretory breast cancer in a 7.5-year old boyJ Szántó, C András, J Tsakiris, et al.
Magyar Onkologia|June 7, 2002
[Clinical and immunopathological significance of chimerism in bone marrow and organ transplantations]A Barta, L Lengyel, A Sipos, et al.
Transplantation Proceedings|February 27, 2016
Early Versus Delayed Autologous Stem Cell Transplantation and Interferon Maintenance in Multiple Myeloma: Single-Center Experience of 18 YearsP Remenyi, G Varga, G Mikala, et al.
Bone Marrow Transplantation|July 7, 2015
The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathyK Balassa, H Andrikovics, P Remenyi, et al.
Human Immunology|March 16, 2000
Immunological importance of chimerism in transplantation: new conditioning protocol in BMT and the development of chimeric stateA Barta, A Bátai, E Kelemen, et al.
Orvosi Hetilap|September 24, 1998
[A new radiation-free conditioning in bone marrow transplantation and dibromo-mannitol therapy in chronic myeloid leukemia]E Kelemen, R Dénes, A Barta, et al.
Acta Haematologica|June 16, 2001
Remarkably reduced transplant-related complications by dibromomannitol non-myeloablative conditioning before allogeneic bone marrow transplantation in chronic myeloid leukemiaA Barta, R Dénes, T Masszi, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Transplantation Proceedings|December 10, 2013
Successful treatment of renal failure caused by multiple myeloma with HLA-identical living kidney and bone marrow transplantation: a case reportL Wagner, L Lengyel, G Mikala, et al.
Leukemia|October 1, 1994
Molecular background of a new case of chronic myelogenous leukemia with bcr-abl chimera mRNA lacking the A2 exonP Páldi-Haris, A Barta, L Lengyel, et al.
Breast (Edinburgh, Scotland)|September 30, 2004
Secretory breast cancer in a 7.5-year old boyJ Szántó, C András, J Tsakiris, et al.
Magyar Onkologia|June 7, 2002
[Clinical and immunopathological significance of chimerism in bone marrow and organ transplantations]A Barta, L Lengyel, A Sipos, et al.
Transplantation Proceedings|February 27, 2016
Early Versus Delayed Autologous Stem Cell Transplantation and Interferon Maintenance in Multiple Myeloma: Single-Center Experience of 18 YearsP Remenyi, G Varga, G Mikala, et al.
Bone Marrow Transplantation|July 7, 2015
The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathyK Balassa, H Andrikovics, P Remenyi, et al.
Human Immunology|March 16, 2000
Immunological importance of chimerism in transplantation: new conditioning protocol in BMT and the development of chimeric stateA Barta, A Bátai, E Kelemen, et al.
Orvosi Hetilap|September 24, 1998
[A new radiation-free conditioning in bone marrow transplantation and dibromo-mannitol therapy in chronic myeloid leukemia]E Kelemen, R Dénes, A Barta, et al.
Acta Haematologica|June 16, 2001
Remarkably reduced transplant-related complications by dibromomannitol non-myeloablative conditioning before allogeneic bone marrow transplantation in chronic myeloid leukemiaA Barta, R Dénes, T Masszi, et al.
Pageof 2